In agreement, ex vivo exposure of CD4+ T cells with SARS-CoV-2 resulted in 10% reduction of cell viability 24 hr after infection with a low MOI (0.1) (Figure 4—figure supplement 3). The gene discussed is CD4; the disease is infection.